Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Tape it to beat shoulder pain? new trial tests simple fix

NCT ID NCT07333417

Symptom relief Sponsor: Hacettepe University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether applying a special rigid tape to the shoulder joint, along with exercises, can reduce pain and improve movement in people with AC joint degeneration. Twenty-eight adults with shoulder pain will be randomly assigned to receive either taping plus exercise or exercise alone for 4 weeks. Researchers will measure pain, range of motion, and daily function at several points, including a 3-month follow-up.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Rigid taping (a type of medical tape applied to the shoulder joint)
What this could lead to
If it works, this could offer a simple, non-drug way to ease shoulder pain and improve daily function for people with AC joint degeneration.
What could go wrong
This is a small, early-stage trial with only 28 participants, so results may not apply to everyone. The taping is temporary and effects may not last beyond the 3-month follow-up.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 28 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jan 2026

An estimate. Start dates often move.

Expected to finish

Apr 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * A clinical diagnosis of acromioclavicular (AC) joint degeneration confirmed by clinical examination and imaging (X-ray, ultrasound, or MRI). * Shoulder pain duration of at least 4 weeks. * Age between 18 and 65 years * Willingness to refrain from any additional treatments outside the study protocol during the study period (e.g., medication changes, injections, or physiotherapy elsewhere) and to provide written informed consent Exclusion Criteria: * Current or previous diagnosis/history of acromioclavicular (AC) joint separation. * Diagnosis of frozen shoulder (adhesive capsulitis). * History of acute trauma or fracture involving the shoulder girdle (e.g., clavicle fracture, shoulder dislocation). * History of shoulder surgery. * Systemic inflammatory joint disease (e.g., rheumatoid arthritis) or other systemic arthropathies. * Skin conditions preventing taping (e.g., rash, open wound, or known tape allergy). * Neuromuscular disease or neurological disorders affecting shoulder function

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acromioclavicular joint are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Shoulder Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acromioclavicular joint Shoulder pain

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hacettepe University, Faculty of Physical Therapy and Rehabilitation, Sports Physiotherapy and Rehabilitation Department

    RECRUITING

    Ankara, Ankara, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.